TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: slowing of the peak horizontal saccade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: dizziness after intake
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive performance deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lapses in behavioral alertness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 6-month continuous abstinent participants
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: sustained abstinent participants
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incremental cost/QALY
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Deep sternal wound infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Probability of death over 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of apolipoprotein B production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MDA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SOD levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ALT level decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: TCRV beta 7 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HBV-DNA and HBeAg negative conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: hypoglycemia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: estimated BG level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall match injury incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: concussion incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acknowledgement of new risks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in PEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: treatment effects on symptom dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weaning off vasopressor support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median duration of vasopressor treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Observer agreement for required intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct identification for needed interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of unneeded obstetric interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Performance index after repair of complete rectal prolapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Condylar repair and regeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of progressive TMJ degeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of SGA (Small for Gestational Age)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous preterm birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Facilitation of LMA insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Breast glandular section thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New breast structure changes
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of elective open surgical repair
Endpoint domain: Mortality/survival
Primary endpoint: Rate of elective endovascular aortic repair
Endpoint domain: Mortality/survival
Primary endpoint: Rate of ruptured open surgical repair
Endpoint domain: Mortality/survival
Primary endpoint: CIN3+ incidence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: CIN2+ incidence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clinical improvement of hyperpigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient satisfaction with FLT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of laser-induced PIH
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in occupational incapacitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased analgesic consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hair count reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hair thickness reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hyperpigmentation
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in knowledge of family medicine
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Development of essential performance skills
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Impact of UI
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in self‐management strategies
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Ability to identify attending physician
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Task workload
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increase in serum 24,25(OH)2D3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lunate extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MACE-free survival rate at one year
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in attention, memory, and orientation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival periods (in days)
Endpoint domain: Mortality/survival
Primary endpoint: Intra-abdominal fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insulin resistance index (LN(HOMA-IR))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time spent on pre-round data gathering per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete relief from epiphora
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PIGO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety profile of BIS
Endpoint domain: Adverse events/effects
Primary endpoint: length of stay in the emergency department
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of laboratory tests performed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: charges associated with tests
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sun exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom relief (heartburn-free days)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Repeat pregnancy
Endpoint domain: Mortality/survival
Primary endpoint: Gestational weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Gestational diabetes mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Gestational hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: DASS‐21 depression subscale reliability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mortality or handicap rate
Endpoint domain: Mortality/survival
Primary endpoint: average of internal and external anal sphincter lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Frequency of urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of cavities free of bacterial contamination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of apnoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blastocyst formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Plasma uracil concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reduced radiographic progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in physical function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Variability in gap widening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in anti-tetanus vaccination of pregnant women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fat infiltration of back muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: signal intensity of back muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: relative CSA of back muscle compartment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: incidence of significant bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical success (resolution of bacteremia signs and symptoms)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Replication Capacity (RC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with botulinum toxin type A treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of preventive tasks performed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of fracture of molar restorations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accurate targeting of the CM using 3T MP2RAGE MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: LDL particle concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LDL cholesterol (LDL-C) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HIV care enrollment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to enrollment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAART initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infection of the obliteration site
Endpoint domain: Adverse events/effects
Primary endpoint: Dry and well-epithelialized mastoid cavities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean trough plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total plasma clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean nonrenal clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-centered communication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of severity of asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with no peristalsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Calorie intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feeding amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Transfer half-life between plasma and effect site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EC50 for miosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of back problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Consultation of regiment infirmary
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: cardiac rejection accompanied by hemodynamic compromise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: motoricity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mobility component change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAC‐1 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl‐Meyer index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catheter indwelling time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of patients with new Gd enhancing lesions that evolved to T1‐hypointense lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients who developed large T1 hypointense lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean proportion per patient of new Gd enhancing lesions that converted to T1‐hypointense lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Regular walking promotion
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: percentage of responders for abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevention of recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correctly upstaged lung cancer patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(max) of levothyroxine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-last) of levothyroxine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to pre-injury function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: abnormalities of absolute FMZ‐Vd
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of women who had mammography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of women who had Papanicolaou testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of women who had colorectal screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Transvalvular gradient (TVG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left ventricular muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: short-term maternal and neonatal morbidity and mortality
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in dysphagia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in eosinophil infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Time to Event (MTE)
Endpoint domain: Mortality/survival
Primary endpoint: Depth of enamel subsurface lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mineral content of enamel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion rate from IGT to DM
Endpoint domain: Mortality/survival
Primary endpoint: Reversion to normal blood glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Alleviation of TCM symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dialysis rate
Endpoint domain: Mortality/survival
Primary endpoint: MWT1 sleep latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discontinuations due to dizziness/vertigo
Endpoint domain: Adverse events/effects
Primary endpoint: unfavourable recovery at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior Knee Pain (AKP) Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of death, myocardial infarction, or TLR
Endpoint domain: Mortality/survival
Primary endpoint: Mortality at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: performance on an EBM skills test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the CTI program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time of onset of sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: V˙o2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of catheter infections
Endpoint domain: Adverse events/effects
Primary endpoint: improvement in dysfunction scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically meaningful improvements in dysfunction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in health as measured by the physical component summary score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Return of organized cardiac electrical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: V̇O2max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug use days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative prevalence of significant anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cumulative prevalence of significant depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cumulative prevalence of worries about cervical cancer
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accessing physician-level quality data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient experience ratings of selected PCPs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: craving for tobacco and marijuana
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sleep during abstinence
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Post-operative nausea and vomiting (PONV) incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Load at failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score after flexion and extension exercises at the 1st day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HSS score at discharge and at 1, 3, and 6 months after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ROM at discharge and at 1, 3, and 6 months after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost to society per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: QALYs gained at 2 years
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient recall of information
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Sense of involvement in decision making
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: maxillary suture opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skeletal changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: buccal bone reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2 peak at 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hb A1c reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: low-density lipoprotein cholesterol reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total pain scores 24h after CPR
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: social interference scores 24h after CPR
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: joint pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical cured rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes